The online version of this article (doi:10.1186/s12882-017-0546-1) contains supplementary material, which is available to authorized users.
Herbert de Groot deceased.
Ischemia and reperfusion (I/R) is one of the major causes of acute kidney injury (AKI). Citrate reduces hypoxia-induced mitochondrial energetic deficits in isolated proximal tubules. Moreover, citrate anticoagulation is now frequently used in renal replacement therapy. In the present study a rat model of I/R-induced AKI was utilized to examine renal protection by citrate in vivo.
AKI was induced by bilateral renal clamping (40 min) followed by reperfusion (3 h). Citrate was infused at three different concentrations (0.3 mmol/kg/h; 0.6 mmol/kg/h and 1.0 mmol/kg/h) continuously for 60 min before and 45 min after ischemia. Plasma calcium concentrations were kept stable by infusion of calcium gluconate. The effect of citrate was evaluated by biomonitoring, blood and plasma parameters, histopathology and tissue ATP content.
In comparison to the normoxic control group bilateral renal ischemia led to an increase of creatinine and lactate dehydrogenase activity and a decrease in tissue ATP content and was accompanied by a drop in mean arterial blood pressure. Infusion of 1.0 mmol/kg/h citrate led to lower creatinine and reduced LDH activity compared to the I/R control group and a tendency for higher tissue ATP content. Pre-ischemic infusion of 1.0 mmol/kg/h citrate stabilized blood pressure during ischemia.
Citrate has a protective effect during I/R-induced AKI, possibly by limiting the mitochondrial deficit as well as by beneficial cardiovascular effects. This strengthens the rationale of using citrate in continuous renal replacement therapy and encourages consideration of citrate infusion as a therapeutic treatment for AKI in humans.
Additional file 1: Figure S1. Ionized plasma chloride levels. Box plots with whiskers indicating minimum and maximum, six rats per group. ** p < 0.01 vs. I/R control group. (PDF 30 kb)12882_2017_546_MOESM1_ESM.pdf
Additional file 2: Figure S2. Urine output. Urine output calculated from samples collected during A 45 min before ischemia B 120–180 min of reperfusion. (PDF 22 kb)12882_2017_546_MOESM2_ESM.pdf
Rodrigue F, Bruetto R, Torres U, Otaviano A, Zanetta D, Burdmann E. Incidence and mortality of acute kidney injury after myocardial infarction: a comparison between KDIGO and RIFLE criteria. PLoS One. 2013;8(7):e69998. CrossRef
Reents W, Hilker M, Börgermann J, Albert M, Plötze K, Zacher M, Diegeler A, Böning A. Acute kidney injury after on-pump or off-pump coronary artery bypass grafting in elderly patients. Ann Thorac Surg. 2014; 98(1):9-14.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1–138. CrossRef
Betjes M, van Oosterom D, van Agteren M, van de Wetering J. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J Nephrol. 2007;20(5):602–8. PubMed
Saner F, Treckmann J, Geis A, Lösch C, Witzke O, Canbay A, Herget-Rosenthal S, Kribben A, Paul A, Feldkamp T. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy. Nephrol Dial Transplant. 2012;27(4):1651–7. CrossRefPubMed
Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P, Kijkriengkraikul N, Leelahavanichkul A, Srisawat N, Praditpornsilpa K, Eiam-Ong S. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration. Ther Apher Dial. 2011;15(6):556–64. CrossRefPubMed
Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75. PubMed
Mitaka C, Si M, Tulafu M, Yu Q, Uchida T, Abe S, Kitagawa M, Ikeda S, Eishi Y, Tomita M. Effects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury. Intensive Care Med Exp. 2014;2(1):28. CrossRefPubMedPubMedCentral
Reid F, Lobo D, Williams R, Rowlands B, Allison S. (Ab)normal saline and physiological Hartmann‘s solution: a randomized double-blind crossover study. Clin Sci (Lond). 2003;104(1):17–24.
Lobo D, Stanga Z, Aloysius M, Wicks C, Nunes Q, Ingram K, Risch L, Allison S. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatin (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med. 2010;38(2):464–70. CrossRefPubMed
Williams E, Hildebrand K, McCormick S, Bedel M. The effect of intravenous lactated Ringer‘s solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg. 1999;88(5):999–1003. PubMed
Kellum JB R, Kramer D, Pinsky M. Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock. 1998;9(5):364–8. CrossRef
Bullivant E, Wilcox C, Welch W. Intrarenal vasoconstriction during hyperchloremia: role of thromboxane. Am J Physiol. 1989;256:F152–157. PubMed
Karajala V, Mansour W, Kellum J. Diuretics and mortality in acute kidney injury. Minverva Anestesiol. 2009;75:251–7.
Zacchia M, Preisig P. Low urinary citrate: an overview. J Nephrol. 2010;23 Suppl 16:49–56.
- Citrate shows protective effects on cardiovascular and renal function in ischemia-induced acute kidney injury
Herbert de Groot
Fuat H. Saner
Joel M. Weinberg
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II